Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Anton I. Seleznev"'
Autor:
Vladimir V. Popov, Yulia N. Linkova, Arina V. Zinkina-Orikhan, Bulat A. Bakirov, Olga M. Moiseeva, Maria A. Morozova, Nikita V. Lomakin, E. Dokukina, A. Eremeeva, Elena S. Pasechnik, Anton A. Lutckii, Mikhail Yu Gilyarov, Mazurov Vi, Anton I. Seleznev, Polina S. Pukhtinskaia, Gaziyavdibir H. Musaev, Elena A Smolyarchuk, Denis N. Protsenko, Dar'ya S. Fomina, Ivan G. Gordeev
Publikováno v:
Inflammation Research
Objective and design The aim of this double-blind, placebo-controlled, phase III CORONA clinical trial was to evaluate the efficacy and safety of IL-6 receptor inhibitor levilimab (LVL) in subjects with severe COVID-19. Subjects The study included 21